Barings Global Short Duration High Yield Fund Announces August 2025 Monthly Distribution of $0.1223 per Share
In addition, the Fund announced estimated monthly dividends of $0.1223 per share for September 2025 and October 2025
The dividend schedule appears below:
The Fund also announced a special distribution of $0.2410 per share payable on September 2, 2025. This special distribution is being paid to allow the Fund to meet its 2024 distribution requirements as a Regulated Investment Company. The Fund anticipates that this distribution will be paid from net investment income.
The following dates apply to the special distribution declared today:
The total amount to be paid on September 2, 2025, inclusive of the regular and special dividend, is $0.3633 per share.
The Fund seeks to pay a distribution at a rate that reflects net investment income actually earned. A portion of each distribution may be treated as paid from sources other than net investment income, including but not limited to short-term capital gain, long-term capital gain or return of capital. The final determination of the source and tax characteristics of these distributions will depend upon the Fund's investment experience during its fiscal year and will be made after the Fund's year end. The Fund will send to investors a Form 1099-DIV for the calendar year that will define how to report these distributions for federal income tax purposes.
The Fund is a non-diversified, closed-end management investment company that is managed by Barings LLC. The Fund invests primarily in short-duration, global high yield bonds with the objective of seeking as high a level of current income as Barings determines is consistent with capital preservation, with a secondary objective of capital appreciation. The Fund expects to maintain a weighted average portfolio duration, including the effects of leverage, of 3 years or less.
Cautionary Notice: Certain statements contained in this press release may be "forward looking" statements. Investors are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date in which they are made and which reflect management's current estimates, projections, expectations or beliefs, and which are subject to risks and uncertainties that may cause actual results to differ materially. These statements are subject to change at any time based upon economic, market or other conditions and may not be relied upon as investment advice or an indication of the Fund's trading intent. References to specific securities are not recommendations of such securities, and may not be representative of the Fund's current or future investments. We undertake no obligation to publicly update forward looking statements, whether as a result of new information, future events, or otherwise.
Past performance is not necessarily indicative of future results.
About Barings
Barings is a $456 billion* global asset management firm that partners with institutional, insurance, and intermediary clients, and supports leading businesses with flexible financing solutions. The firm, a subsidiary of MassMutual, seeks to deliver excess returns by leveraging its global scale and capabilities across public and private markets in fixed income, real assets and capital solutions.
1 Amounts represent estimates for September and October.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a minute ago
- Yahoo
EDS Service Solutions Named to the Inc. 5000 List for Third Consecutive Year
ATLANTA, August 14, 2025--(BUSINESS WIRE)--EDS Service Solutions has been recognized on the 2025 Inc. 5000 list, the annual ranking of the nation's fastest-growing private companies, for the third year in a row. EDS ranked No. 3607 overall, No. 154 in the Atlanta–Sandy Springs–Alpharetta, Georgia market, No. 362 in the Business Products and Services industry, and No. 173 in Georgia. The Inc. 5000 provides a data-driven look at the most successful privately held, independent businesses in the economy's most dynamic sectors. Many well-known companies first gained national exposure as Inc. 5000 honorees. "Being recognized on the Inc. 5000 list for the third consecutive year is a powerful testament to our team's unwavering resilience, creativity, and relentless commitment," said Sonya Locke, CEO of EDS Service Solutions. "This sustained growth and ranking among the nation's fastest-growing companies underscores the immense value we deliver to our client partnerships every day. Our continued growth is a testament to our expertise in providing top-tier staffing solutions services and human capital management across various industries. We are proud to stand alongside so many innovative organizations that are driving economic growth and shaping the future of business." On the 2025 Inc. 5000 list, the median revenue growth rate for honorees was 169 percent for the three-year period from 2021 to 2024. Hundreds of top-ranking companies achieved growth rates more than 100 times that median. This level of growth is particularly notable given the economic volatility, rapid innovation, political uncertainty, and other challenges businesses have navigated over the past several years. About EDS Service Solutions EDS Service Solutions, a women-led enterprise headquartered in Atlanta, Georgia, specializes in labor outsourcing and business process optimization. The company serves industries including car rental, automotive, hospitality, aviation, travel, and logistics, operating in the U.S. Top 30 airports with over 150 locations nationwide. EDS combines business process outsourcing, human capital management, recruitment process outsourcing, and staff augmentation into a unified strategy that improves operational efficiency and advances client success. To learn more, visit Methodology Companies on the 2025 Inc. 5000 are ranked according to percentage revenue growth from 2021 to 2024. To qualify, companies must be U.S.-based, privately held, for-profit, and independent, not subsidiaries or divisions of other companies, as of December 31, 2024. They must have generated revenue by March 31, 2021, with a minimum of $100,000 in 2021 and $2 million in 2024. About Inc. Inc. Business Media is the leading multimedia brand for entrepreneurs. Through its award-winning journalism, Inc. informs, educates, and elevates the profile of risk-takers, innovators, and ultra-driven go-getters shaping the future. Its proprietary Inc. 5000 list, produced every year since 1982, ranks the fastest-growing privately held businesses in the United States. Inclusion provides founders with access to an exclusive community of peers and credibility that can help drive sales and attract talent. For more information, visit View source version on Contacts Media Contact:Sophia Sasso404-567-6657ssasso@
Yahoo
a minute ago
- Yahoo
Nasus Pharma Announces Closing of Initial Public Offering
TEL AVIV, Israel, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) ('Nasus Pharma' or the 'Company'), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products to treat emergency medical conditions, today announced the closing of its initial public offering of 1,250,000 ordinary shares ('Ordinary Shares') at a public offering price of $8.00 per Ordinary Share. The gross proceeds of the offering were $10 million, prior to deducting underwriting discounts, commissions, and other offering expenses. Nasus Pharma's shares began trading on the NYSE American LLC exchange on August 13, 2025 under the ticker symbol 'NSRX'. Nasus Pharma has granted the underwriters an option for a period of up to 45 days from the date of the final prospectus, to purchase up to an additional 187,500 Ordinary Shares at the initial public offering price, less the underwriting discounts and commissions. The Company intends to use the net proceeds from the initial public offering for furthering the development of its intranasal Epinephrine program, including, manufacturing scale-up and additional Phase 2 studies, and the remainder for general and administrative corporate purposes, including working capital, and capital expenditures. Laidlaw & Company (UK) Ltd. and Craft Capital Management LLC acted as Joint Bookrunners for the offering. A registration statement on Form F-1 (File No. 333-288582) (the 'Registration Statement') relating to the initial public offering was filed with the Securities and Exchange Commission ('SEC') and declared effective by the SEC on August 12, 2025. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities referred to herein nor shall there be any sale of such securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. The offering was made only by means of a prospectus forming a part of the Registration Statement. A copy of the final prospectus relating to this offering has been filed with the SEC and copies of the final prospectus can be obtained by contacting Laidlaw & Company (UK) Ltd., 521 Fifth Ave, 12th Floor, New York, NY 10075, or by calling 212-953-4900 or by e-mailing syndicate@ About Nasus Pharma Nasus Pharma is a clinical-stage pharmaceutical company developing a number of intranasal powder products addressing acute medical conditions in the community. NS002, Nasus's intranasal powder Epinephrine product candidate is being developed as a needle-free alternative to Epinephrine autoinjectors for patients with anaphylaxis. Intranasal administration is most suitable for those situations in which rapid drug delivery is required and offers needle free, easy to use alternatives. Nasus proprietary powder-based intranasal ('PBI') technology is designed for rapid and reliable drug delivery, leveraging the nasal cavity's rich vascular network for quick absorption. The PBI formulation uses uniform spherical powder particles for broad dispersion and potentially faster, higher absorption compared to liquid-based nasal products. Forward Looking Statements This press release contains 'forward-looking statements' that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements, including, among other things: statements related to the expected use of proceeds from the Company's initial public offering. Forward-looking statements contained in this press release may be identified by the use of words such as 'anticipate,' 'believe,' 'contemplate,' 'could,' 'estimate,' 'expect,' 'intend,' 'seek,' 'may,' 'might,' 'plan,' 'potential,' 'predict,' 'project,' 'target,' 'aim,' 'should,' "will' 'would,' or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on the Company's current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. These and other risks and uncertainties are described more fully in the section titled 'Risk Factors' in the final prospectus related to the initial public offering filed with the SEC. Forward-looking statements contained in this announcement are made as of this date, and the Company undertakes no duty to update such information except as required under applicable law. Contactinfo@ Pharma Ltd. Israelhttps:// Investor ContactMike MoyerLifeSci Advisors+1-617-308-4306mmoyer@
Yahoo
a minute ago
- Yahoo
Why Deere (DE) Stock Is Nosediving
What Happened? Shares of agricultural and construction machinery company Deere (NYSE:DE) fell 7.9% in the morning session after the company reported second-quarter results that, despite beating revenue expectations, showed a significant year-over-year decline in profitability. While the company's revenue grew 5.5% year-over-year to $12.02 billion, surpassing analyst forecasts, investors focused on the weakening bottom line. Deere's earnings per share fell to $4.75 from $6.29 in the same quarter last year, although this figure did beat Wall Street's estimates. A key area of concern for investors was the company's shrinking profitability. The operating margin, a measure of core business profitability, contracted sharply to 13% from 20.2% a year ago, indicating that expenses grew faster than revenue. This significant decline in operational efficiency and the steep drop in year-over-year earnings appeared to outweigh the positive sales news, prompting a negative reaction from the market. The shares closed the day at $478.61, down 6.7% from previous close. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Deere? Access our full analysis report here, it's free. What Is The Market Telling Us Deere's shares are not very volatile and have only had 4 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business. The biggest move we wrote about over the last year was 9 months ago when the stock gained 8.5% on the news that the company reported impressive third-quarter results that exceeded analysts' revenue and EPS estimates. Looking ahead, the company initiated fiscal 2025 guidance, calling for revenues down 10-15% year on year. While this may sound like a negative, it does show that end markets are not getting worse and may be reaching a trough. Zooming out, we think this was a good quarter with guidance showing that demand may be hitting a bottom in 2025 and poised for an uptick thereafter, especially if themes like reshoring and industrial automation become more real. Deere is up 14.5% since the beginning of the year, but at $478.71 per share, it is still trading 9.9% below its 52-week high of $531.48 from May 2025. Investors who bought $1,000 worth of Deere's shares 5 years ago would now be looking at an investment worth $2,505. Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
